INAB
IN8bio, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B
Company Profile
CEO
William T.
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
IN8bio, Inc.
CEO
William T.
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 154,500 |
| $1.58 |
| 12 May 2026 | Greenwood Luba | director | A-Award | Acquired | 22,000 | $1.58 |
| 12 May 2026 | Lamb Lawrence | EVP and CSO | A-Award | Acquired | 54,000 | $1.58 |
| 12 May 2026 | FAIRBAIRN EMILY | director | A-Award | Acquired | 22,000 | $1.58 |
| 12 May 2026 | McCall Patrick | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 56,250 | $1.58 |
| 12 May 2026 | Epperly Corinne | director | A-Award | Acquired | 22,000 | $1.58 |
| 12 May 2026 | Rochlin Kate | President and COO | A-Award | Acquired | 60,000 | $1.58 |
| 12 May 2026 | Brandt Peter C. | director | A-Award | Acquired | 22,000 | $1.58 |
| 12 May 2026 | Graff Jeremy R. | director | A-Award | Acquired | 22,000 | $1.58 |